0001104659-20-085611.txt : 20200722
0001104659-20-085611.hdr.sgml : 20200722
20200722160252
ACCESSION NUMBER: 0001104659-20-085611
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20200720
FILED AS OF DATE: 20200722
DATE AS OF CHANGE: 20200722
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Necina Roman
CENTRAL INDEX KEY: 0001794381
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38869
FILM NUMBER: 201041543
MAIL ADDRESS:
STREET 1: C/O HOOKIPA PHARMA INC.
STREET 2: 350 FIFTH AVENUE, 72ND FLOOR, SUITE 7240
CITY: NEW YORK
STATE: NY
ZIP: 10118
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: HOOKIPA Pharma Inc.
CENTRAL INDEX KEY: 0001760542
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 815395687
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 430 EAST 29TH STREET
STREET 2: 14TH FLOOR
CITY: NEW YORK
STATE: NY
ZIP: 10016
BUSINESS PHONE: 0114318906360
MAIL ADDRESS:
STREET 1: 430 EAST 29TH STREET
STREET 2: 14TH FLOOR
CITY: NEW YORK
STATE: NY
ZIP: 10016
4
1
a4.xml
4
X0306
4
2020-07-20
0
0001760542
HOOKIPA Pharma Inc.
HOOK
0001794381
Necina Roman
C/O HOOKIPA PHARMA INC.,
350 FIFTH AVENUE, 72ND FLOOR, SUITE 7240
NEW YORK
NY
10118
0
1
0
0
Chief Technology Officer
Common Stock
2020-07-20
4
A
0
1984
0
A
1984
D
The Reporting Person was awarded 1,984 restricted stock units. Each restricted stock unit represents a contingent right to receive one share of HOOKIPA Pharma Inc.'s Common Stock. The restricted stock units vest shall vest in four equal installments on March 20, 2021, May 15, 2021, August 15, 2021 and November 15, 2021. The restricted stock units may be settled only by delivering shares of HOOKIPA Pharma Inc.'s Common Stock, and thus, the grant is being reported in Table 1 as allowed per SEC guidance.
/s/ Reinhard Kandera, as Attorney-in-Fact
2020-07-22